Clinical Trial Update: Effect of Bazedoxifene, Raloxifene, and Placebo on Breast Density

View source ↗

Summary

This clinical trial compared bazedoxifene, raloxifene, and placebo to assess their effects on breast density; the study sponsored by Wyeth/Pfizer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bazedoxifene (bazedoxifene)
• Raloxifene (raloxifene)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Breast Cancer | Status: COMPLETED